These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37924792)

  • 21. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
    Daru; 2011; 19(1):23-32. PubMed ID: 22615636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
    Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsoriatic and Anti-inflammatory Studies of
    Nimisha ; Rizvi DA; Fatima Z; Neema ; Kaur CD
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S587-S594. PubMed ID: 29142419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
    Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
    Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical Delivery of
    Chinembiri TN; Gerber M; du Plessis LH; du Preez JL; Hamman JH; du Plessis J
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S663-S671. PubMed ID: 29142430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
    Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
    Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
    Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
    Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
    Dasgupta S; Ghosh SK; Ray S; Mazumder B
    Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice.
    Liang L; Fei WM; Zhao ZQ; Hao YY; Zhang C; Cui Y; Guo XD
    Eur J Pharm Biopharm; 2021 Jul; 164():20-27. PubMed ID: 33895291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers.
    Gokce EH; Korkmaz E; Tuncay-Tanrıverdi S; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():5109-17. PubMed ID: 23055723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms.
    Sunkari S; Thatikonda S; Pooladanda V; Challa VS; Godugu C
    Int Immunopharmacol; 2019 Jun; 71():301-312. PubMed ID: 30933843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
    Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
    Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis.
    Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL
    Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis.
    Tripathi P; Kumar A; Jain PK; Patel JR
    Int J Biol Macromol; 2018 Dec; 120(Pt A):1322-1334. PubMed ID: 30171962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications.
    Kalariya M; Padhi BK; Chougule M; Misra A
    Indian J Exp Biol; 2005 Mar; 43(3):233-40. PubMed ID: 15816409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles.
    Marto J; Sangalli C; Capra P; Perugini P; Ascenso A; Gonçalves L; Ribeiro H
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1792-1800. PubMed ID: 28581831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
    Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
    Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
    Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.